Clinical Trial

Effects of Selected Statins on Blood Glucose Levels in Healthy Volunteers

Study acronym: [Statins]
Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This Phase I randomized clinical trial aims to investigate the short-term effects of three commonly prescribed statins (atorvastatin, rosuvastatin, and simvastatin) at different dose levels on blood glucose homeostasis in healthy volunteers. The study will assess changes in fasting blood glucose, insulin, and C-peptide levels following two days of statin administration under controlled conditions. The research seeks to provide comparative data on the potential diabetogenic effects of these medications.
Trial Details
NCT Number NCT07378293
Lead Sponsor Shaheed Benazir Bhutto University Sheringal Dir Upper
Collaborators: Khyber Medical University Peshawar
Conditions Diabete Mellitus, Lipid Profile
Enrollment 100 participants
Start Date 2026-03-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-02-20 (estimated)
Updated on ClinicalTrials.gov 2026-01-30